Ocular Regenerative Medicine – Translational Medicine: From bench to bedside
My Session Status
When:
10:45 AM, Friday 1 Jun 2018
(1 hour 30 minutes)
Breaks:
Lunch 12:15 PM to 01:30 PM (1 hour 15 minutes)
Where:
Theme:
Ocular Regenerative Medicine
LEARNING OBJECTIVES
At the end of this session, participants will be able to:
At the end of this session, participants will be able to:
- Assess the need for a limbal stem cell ex vivo expansion program in North America
- Describe a novel surgical procedure for dealing with recalcitrant pterygiums
- Illustrate how neurotinization surgery can be used to treat patients suffering from anaesthetic corneas
Sub Sessions
10:45 AM -
11:00 AM |
15 minutes
11:05 AM -
11:15 AM |
10 minutes
11:18 AM -
11:28 AM |
10 minutes
Authors: Tanguy Boutin, Zale Mednick, Allan Slomovic Author Disclosure Block: T. boutin: None. Z. Mednick: None. A. Slomovic: Employment/honoraria/consulting fees; Name of Commercial Company(s); Alcon Canada, Bausch and Lomb Canada. Membership on an advisory panel, standing committee or board of directors; Name of Commercial Company(s); Allergan, Santen, Shire Canada, AMO. Abstract Body: Purpose: To show a novel surgical procedure to tre...
11:31 AM -
11:46 AM |
15 minutes
11:49 AM -
11:59 AM |
10 minutes